Obesity
| Weight loss
Obesity
Weight loss
Evaluating Health-Related Quality of Life With Tirzepatide in the SURMOUNT-1 Study
book_2
Source:
ObesityWeek 2022 - Session summary
calendar_today
Published on Medfyle:
November 2022
import_contacts
5
min
In this medfyle
In SURMOUNT-1, compared to placebo, tirzepatide significantly improved physical and psychosocial function.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of an oral session given at the ObesityWeek® 2022 and presented by:
Jiat Ling Poon, PhD
Eli Lilly and Company
Indianapolis, IN, USA
The content is produced by Infomedica. The presenting authors of the original session had no part in the creation of this conference summary.
